GlobeStar Therapeutics Corp

GlobeStar Therapeutics Corp

GSTC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$124.11K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
GlobeStar Therapeutics CorpGlobeStar Therapeutics Corp0-55%--0.1
$-0.00

Current Fair Value

500% downside

Overvalued by 500% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$124,111.00
Enterprise Value$211,843.00
Earnings per Share$0
Beta1.12
Outstanding Shares1,208,972,000

Return

Return on Equity54.58%ROE
Return on Assets-1057.49%
Return on Invested Capital49.09%

Valuation & Multiples

P/E Ratio-0.04P/E Ratio
PEG0.05PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.27
Enterprise Value to Net Income-1
Total Debt to Enterprise0.41
Debt to Equity-0.05Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About GlobeStar Therapeutics Corp

1 employees

GlobeStar Therapeutics Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.